loader2
NRI

Feb 12, 2025


Category

Equity

AUM (Cr.)

8,160.74

Exit Load (%)

0.00

Min Inv Lumpsum

5,000

Expense Ratio

1.82

Sharpe Ratio

8.57

Beta Ratio

0.00

Fund Manager

Sailesh Raj Bhan

Inception Date

Jun 05, 2004

Risk Level

Very High

Investment Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Pharma Fund (IDCW) -7.54 -5.13 10.01 18.13 23.59 20.34
Benchmark - S&P BSE Healthcare 14.73 38.57 53.75 13.45 1.76 0
Category Average - BEST EQUITY PERFORMERS -5.43 -8.26 9.21 15.28 18.57 10.43
Category Rank 6/10 4/10 5/10 7/10 7/10 10/10
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Motilal Oswal Business Cycle Fund - Regular (G) 11.2773 0.77 0.00 0.00 0.00 1,645.05 2.03 500.00 invest
Motilal Oswal Business Cycle Fund - Regular (IDCW) 11.2774 0.77 0.00 0.00 0.00 1,645.05 2.03 500.00 invest
WhiteOak Capital Digital Bharat Fund - Regular (G) 9.4630 0.71 0.00 0.00 0.00 308.36 0.00 500.00 invest
Bank of India Consumption Fund - Regular (IDCW) 9.6300 0.63 0.00 0.00 0.00 406.61 2.25 5,000.00 invest
ICICI Pru Banking & Financial Services (IDCW) 27.5000 -16.94 14.76 11.61 10.91 9,045.56 1.82 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Jan 31, 2025 1,143.39 14.01 -7.55
Equity-Divi`s Lab. Jan 31, 2025 753.44 9.23 -8.54
Equity-Lupin Jan 31, 2025 665.89 8.16 -11.77
Equity-Cipla Jan 31, 2025 458.61 5.62 -3.24
Equity-Dr Reddy`s Labs Jan 31, 2025 445.81 5.46 -12.33
Equity-Apollo Hospitals Jan 31, 2025 441.86 5.41 -6.66
Equity-Vijaya Diagnost. Jan 31, 2025 294.22 3.61 -7.98
Equity-Ajanta Pharma Jan 31, 2025 258.48 3.17 -8.11
Equity-Medplus Health Jan 31, 2025 257.85 3.16 -12.94
Equity-Gland Pharma Jan 31, 2025 233.19 2.86 -12.63

latest news

Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 14 February 2025 as the record date ...

Feb 12, 2025 09:29

Nippon India launches Active Momentum Fund

Nippon India Mutual Fund has announced the launch of the Nippon India Activ...

Feb 10, 2025 15:02

Nippon India MF announces Income Distribution cum Capital Withdrawal (IDCW) under two schemes

Nippon India Mutual Fund has announced 06 February 2025 as the record date ...

Feb 04, 2025 09:39

Nippon India MF announces change in fund manager under its schemes

Nippon India Mutual Fund has announced change in fund managers under the fo...

Feb 03, 2025 10:12

Nippon India MF announces change in benchmark index under its scheme

Nippon India Mutual Fund has announced change in the Benchmark of the follo...

Jan 31, 2025 11:38

Nippon India Mutual Fund announces Income Distribution cum Capital Withdrawal (IDCW) under two schemes

Nippon India Mutual Fund has announced 30 January 2025 as the record date f...

Jan 28, 2025 10:45

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Pharma Fund (IDCW)
Contact Persone : Sailesh Raj Bhan
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com